查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1745009

全球生物製药物流市场

Bio-pharma Logistics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 231 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球生物製药物流市场规模将达1,729亿美元

全球生物製药物流市场规模预计在2024年为1,096亿美元，到2030年将达到1,729亿美元，在2024-2030年的分析期间内，复合年增长率为7.9%。低温运输物流是本报告分析的细分领域之一，预计其复合年增长率为6.4%，到分析期结束时规模将达到1042亿美元。非低温运输物流领域在分析期间的复合年增长率预计为10.4%。

美国市场规模估计为 288 亿美元，中国市场预计复合年增长率为 7.7%

2024年，美国生物製药物流市场规模估计为288亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到278亿美元，在2024-2030年的分析期内，复合年增长率为7.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为7.0%和6.8%。在欧洲，预计德国市场的复合年增长率约为6.5%。

全球生物製药物流市场－主要趋势与驱动因素摘要

为什么生物製药物流正在成为产品完整性、低温运输规性和全球治疗范围的战略支柱？

生物製药物流已发展成为生命科学价值链中一项关键任务，支持高价值药品、生技药品、疫苗以及细胞和基因治疗产品的安全、及时、温控配送。随着产品复杂性和敏感性的不断提高，物流如今在保障治疗效果、法规遵循和市场准入方面发挥核心作用。从「第一英里」的原料药运输到「最后一哩路」的临床交付，物流供应商正逐渐融入更广泛的商业化和供应连续性策略。

随着单株抗体、mRNA 疫苗和 CAR-T 疗法等温敏性生技药品的兴起，端对端低温运输物流的重要性日益凸显。这些产品需要严格的温度范围（通常为 2-8°C、-20°C 或 -80°C 低温储存），并且必须即时监控，以防止可能影响产品活性的温度超调。分散式临床试验、直接面向患者的配送模式以及全球疫苗项目的扩展，进一步提高了对物流基础设施、可视性和可追溯性的需求。

除了温度控制之外，生物製药物流还必须应对与产品保质期、法规协调、清关和运输安全相关的挑战。由于生技药品和先进疗法具有极高的经济价值和治疗价值，物流链中的任何中断都可能对临床和经济造成重大影响。因此，製药公司正在重新评估物流作为一项战略能力，选择合作伙伴时不仅要考虑成本，还要考虑品质保证、合规性以及技术准备。

低温运输技术、即时视觉性和风险缓解策略如何塑造生物製药物流能力。

低温运输创新处于物流转型的前沿。相变材料、真空隔热包装板和可重复使用的热感运输箱等先进包装解决方案正在引入，以便在长时间运输和各种气候条件下保持温度。采用干蒸气氮技术的低温容器越来越多地用于运输细胞和基因疗法，在这些领域，超低温的稳定性至关重要。

支援物联网的数据记录器、GPS 追踪器和云端基础仪表板，提供位置、温度、衝击、光照和湿度的详细洞察。这些工具使物流经理能够在出现偏差时主动干预，转移敏感货物，并维护监管文件的审核线索。与仓库管理系统 (WMS)、运输管理系统 (TMS) 和基于区块链的平台集成，进一步增强了可追溯性和监管链保障。

降低风险是生物製药物流的首要任务，尤其是在高风险地区和疫情期间。紧急计画、路线认证、双供应商低温运输设定和冗余储存节点越来越多地被纳入物流策略，以确保供应的连续性。 FDA、EMA 和 WHO 等监管机构正在对运输验证、温度测绘和偏差响应通讯协定进行更严格的控制，这增加了对符合 GxP 营运和药品级品质系统的物流合作伙伴的需求。

哪些治疗领域、全球分销网络和策略伙伴关係正在推动对专业生物製药物流的需求？

细胞和基因疗法、个人化癌症疫苗以及基于RNA的生技药品等先进疗法是生物製药物流市场的主要成长要素。这些治疗方法通常可行性有限，需要即时交付模式，并由拥有全球患者群体的集中式设施生产。免疫肿瘤学、罕见疾病、下一代疫苗等领域临床试验的激增，进一步增加了生技药品在物流链中流通的数量和复杂性。

全球物流网络正在适应亚太、中东和拉丁美洲新兴丛集的需求，这些集群正在扩大其生产和临床试验业务。为降低运输风险并加快治疗速度，这些集群正在策略性地建立配备GDP认证设施、区域冷藏和多模态的物流丛集。虽然北美和西欧仍然是中心枢纽，但製造的分散化和在地化正在推动向更敏捷、更分散的物流转变。

製药公司、第三方物流供应商、包装供应商和技术赋能者之间的策略伙伴关係正在重新定义物流系统。路线检验通讯协定、共用风险模型和数位整合平台的共同开发，正在实现端到端的可视性和基于绩效的物流管理。随着製药商转向更精简、需求主导的供应链，物流合作伙伴在规划週期的早期就被纳入其中，共同设计针对特定治疗方案和监管途径的解决方案。

生物製药物流市场的成长要素是什么？

随着生命科学领域朝向复杂、温度敏感且以患者为中心的治疗方法发展，生物製药物流市场也随之扩张，这些疗法需要精准且合规的物流解决方案。如今，物流已成为治疗成功、病人安全和商业性扩充性的关键推动因素。

关键成长动力包括低温运输依赖型生技药品和先进疗法的普及、全球临床临床实验的扩展、端到端可视性的监管要求，以及对分散式和敏捷交付模式日益增长的需求。技术创新、策略性外包和垂直整合的服务模式正在进一步加速市场的发展。

随着生物製药管道转向更个人化、更高价值的疗法，物流能否成为竞争优势，从后端功能转变为创造价值、降低风险并与创新保持一致的下一代药物输送的支柱？

部分

类型（低温运输物流、非低温运输物流）、服务类型（运输、仓储、包装、其他服务类型）、应用（生技药品、处方药、非处方药、原料/原料药、其他应用）

调查企业范例（共42家企业）

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne+Nagel
  • LifeConEx
  • Marken（a UPS Company）
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service（UPS）
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP34706

Global Bio-pharma Logistics Market to Reach US$172.9 Billion by 2030

The global market for Bio-pharma Logistics estimated at US$109.6 Billion in the year 2024, is expected to reach US$172.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$104.2 Billion by the end of the analysis period. Growth in the Non-Cold Chain Logistics segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.8 Billion While China is Forecast to Grow at 7.7% CAGR

The Bio-pharma Logistics market in the U.S. is estimated at US$28.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Bio-pharma Logistics Market - Key Trends & Drivers Summarized

Why Is Bio-pharma Logistics Emerging as a Strategic Pillar for Product Integrity, Cold Chain Compliance, and Global Therapeutic Reach?

Bio-pharma logistics has evolved into a mission-critical function within the life sciences value chain, underpinning the secure, timely, and temperature-controlled distribution of high-value pharmaceuticals, biologics, vaccines, and cell and gene therapies. With increasing product complexity and sensitivity, logistics now plays a central role in safeguarding therapeutic efficacy, regulatory compliance, and market access. From first-mile API transport to last-mile clinical delivery, logistics providers are being integrated into broader commercialization and supply continuity strategies.

The rise of temperature-sensitive biologics-including monoclonal antibodies, mRNA vaccines, and CAR-T therapies-has amplified the importance of end-to-end cold chain logistics. These products require stringent temperature ranges (typically 2-8°C, -20°C, or even cryogenic storage at -80°C) and must be monitored in real time to prevent thermal excursions that can compromise product viability. The expansion of decentralized clinical trials, direct-to-patient delivery models, and global vaccine programs has placed further demands on logistics infrastructure, visibility, and traceability.

Beyond temperature control, bio-pharma logistics must address challenges related to product shelf life, regulatory harmonization, customs clearance, and security in transit. With biologics and advanced therapies commanding high economic and therapeutic value, any disruption in the logistics chain can have far-reaching clinical and financial consequences. As a result, pharmaceutical companies are re-evaluating logistics as a strategic capability-selecting partners not just on cost but on quality assurance, compliance strength, and technological readiness.

How Are Cold Chain Technologies, Real-Time Visibility, and Risk Mitigation Strategies Reshaping Logistics Capabilities in Bio-pharma?

Cold chain innovation is at the forefront of logistics transformation. Advanced packaging solutions-such as phase-change materials, vacuum-insulated panels, and reusable thermal shippers-are being deployed to maintain temperature integrity over extended transit times and varied climatic conditions. Cryogenic containers with dry vapor nitrogen technology are increasingly used for cell and gene therapy shipments, where ultra-low temperature stability is non-negotiable.

Real-time visibility tools are becoming standard across critical lanes, with IoT-enabled data loggers, GPS trackers, and cloud-based dashboards providing granular insights into location, temperature, shock, light, and humidity. These tools allow logistics managers to intervene proactively in case of deviations, reroute sensitive shipments, and maintain audit trails for regulatory documentation. Integration with warehouse management systems (WMS), transport management systems (TMS), and blockchain-based platforms further enhances traceability and chain-of-custody assurance.

Risk mitigation is a key priority in bio-pharma logistics, particularly in high-risk geographies or during pandemic-level disruptions. Contingency planning, route qualification, dual-vendor cold chain setups, and redundant storage nodes are increasingly embedded in logistics strategies to ensure continuity of supply. Regulatory agencies such as the FDA, EMA, and WHO are mandating stricter controls on transport validation, temperature mapping, and deviation response protocols-reinforcing the need for logistics partners with GxP-compliant operations and pharmaceutical-grade quality systems.

Which Therapeutic Segments, Global Distribution Networks, and Strategic Partnerships Are Driving Demand for Specialized Bio-pharma Logistics?

Advanced therapies-including cell and gene therapies, personalized cancer vaccines, and RNA-based biologics-are the primary growth drivers in the bio-pharma logistics market. These therapies often have narrow windows of viability, require just-in-time delivery models, and are produced in centralized facilities with global patient bases. The surge in clinical trials across immuno-oncology, rare diseases, and next-generation vaccines is further increasing the volume and complexity of biologics moving through the logistics chain.

Global distribution networks are adapting to meet demand from emerging bio-clusters in Asia-Pacific, the Middle East, and Latin America, which are expanding manufacturing and clinical trial operations. Logistics hubs with GDP-certified facilities, regional cold storage, and multi-modal integration are being strategically established to reduce transit risk and enable faster time-to-therapy. North America and Western Europe remain central nodes, but decentralization and localization of manufacturing are prompting a shift toward more agile and distributed logistics architectures.

Strategic partnerships between pharma companies, 3PL providers, packaging vendors, and technology enablers are redefining the logistics ecosystem. Co-development of route validation protocols, shared risk models, and digital integration platforms is enabling end-to-end visibility and performance-based logistics management. As pharma manufacturers move toward leaner, demand-driven supply chains, logistics partners are being embedded earlier in planning cycles to co-design solutions tailored to specific therapy profiles and regulatory pathways.

What Are the Factors Driving Growth in the Bio-pharma Logistics Market?

The bio-pharma logistics market is expanding as the life sciences sector transitions toward complex, temperature-sensitive, and patient-centric therapies that demand high-precision, compliant logistics solutions. Logistics is now a critical enabler of therapeutic success, patient safety, and commercial scalability.

Key growth drivers include the proliferation of cold chain-dependent biologics and advanced therapies, expanding global clinical trials, regulatory mandates for end-to-end visibility, and rising demand for decentralized, agile delivery models. Technological innovation, strategic outsourcing, and vertically integrated service models are further accelerating market evolution.

As biopharma pipelines shift toward individualized, high-value therapeutics, could logistics become the competitive differentiator-transforming from a backend function into a value-generating, risk-mitigating, and innovation-aligned pillar of next-generation pharmaceutical delivery?

SCOPE OF STUDY:

The report analyzes the Bio-pharma Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Cold Chain Logistics, Non-Cold Chain Logistics); Service Type (Transportation, Warehousing, Packaging, Other Service Types); Application (Biologics, Prescribed Drugs, Over-the-Counter Medicines, Raw Materials & Bulk Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne + Nagel
  • LifeConEx
  • Marken (a UPS Company)
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service (UPS)
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bio-pharma Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Temperature-Sensitive Biologics Throws the Spotlight on Specialized Bio-Pharma Logistics
    • Growth in Cell and Gene Therapy Markets Spurs Investment in Ultra-Cold Chain and Cryogenic Transportation
    • OEM Integration of Real-Time Monitoring and GPS Tracking Technologies Enhances Shipment Visibility and Integrity
    • Expansion of Just-in-Time Manufacturing and Direct-to-Patient Delivery Models Fuels Demand for Agile Logistics
    • OEM Focus on Lane Qualification, Regulatory Compliance, and GDP Certification Strengthens Provider Credibility
    • Growth in Biologics and Clinical Trial Logistics Drives Need for Time-Critical, High-Compliance Transport Networks
    • Adoption of Blockchain and Data Logging Solutions Enhances Chain-of-Custody Verification
    • Strategic Placement of Biopharma Logistics Hubs Near Manufacturing and Clinical Trial Centers Improves Responsiveness
    • Rise of Biopharma Outsourcing and Global CDMO Partnerships Supports 3PL and 4PL Market Expansion
    • Investment in Reverse Logistics and Packaging Reusability Supports Sustainability Goals in Pharmaceutical Transport
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bio-pharma Logistics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Raw Materials & Bulk Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Prescribed Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Over-the-Counter Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Warehousing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION